Literature DB >> 6376129

Plasminogen activator and cancer.

M J Duffy, P O'Grady.   

Abstract

Plasminogen activator is a protease which catalyses the conversion of the inactive plasminogen to the active plasmin. Most transformed cell lines and solid tumors produce elevated levels of plasminogen activator compared with nontransformed counterparts. This increased synthesis of plasminogen activator may play a role in tumorigenesis, cancer invasion and metastasis. Measurement of plasminogen activator in tumor extracts and body fluids may provide diagnostic and prognostic information. Finally, since plasminogen activator is an estradiol-inducible enzyme, its measurement in breast carcinomas might be a marker for a functional estrogen receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376129     DOI: 10.1016/0277-5379(84)90001-4

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  14 in total

1.  Identification of a plasminogen activator derived from nasopharyngeal carcinoma.

Authors:  T Kosugi; G W Huang; M Nakamura; S Koja; H T Nong
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma).

Authors:  C van Haaften-Day; P Russell; S Carr; L Wright
Journal:  In Vitro Cell Dev Biol       Date:  1988-10

3.  The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.

Authors:  S M Abidi; E W Howard; J J Dmytryk; J T Pento
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

4.  Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus.

Authors:  Aron Altorjay; Balazs Paal; Nicolette Sohar; Janos Kiss; Imre Szanto; Istvan Sohar
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

5.  Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence?

Authors:  J S Gelister; M R Lewin; H E Driver; F Savage; M Mahmoud; P J Gaffney; P B Boulos
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

6.  Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.

Authors:  Q Dong; M H Zhou; V Subbarao; C H Ts'ao
Journal:  Br J Exp Pathol       Date:  1988-10

7.  Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.

Authors:  P A de Bruin; H W Verspaget; G Griffioen; J H Verheijen; G Dooijewaard; C B Lamers
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

8.  Paracrine control of differentiation in the alveolar carcinoma, A549, by human foetal lung fibroblasts.

Authors:  V Speirs; K P Ray; R I Freshney
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

9.  In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.

Authors:  L Ossowski; G Clunie; M T Masucci; F Blasi
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

10.  Role for different cell proteinases in cancer invasion and cytolysis.

Authors:  S Zucker; G Beck; J F DiStefano; R M Lysik
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.